Company Filing History:
2 out of 321 
1 out of 549 
Years Active: 2012-2017
Title: Sang Jick Kim: Innovator in Monoclonal Antibody Research
Introduction
Sang Jick Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment and diagnosis.
Latest Patents
One of his latest patents is a monoclonal antibody specifically bound to the TM4SF5 protein. This invention relates to a novel monoclonal antibody that targets the human TM4SF5 protein, along with methods for treating liver fibrosis and cancer. Additionally, he has developed humanized anti-TAG-72 monoclonal antibodies, which are designed to enhance antigen binding affinity and are used in anticancer compositions.
Career Highlights
Sang Jick Kim has worked with notable organizations such as the Korea Research Institute of Bioscience and Biotechnology and the Snur & Db Foundation. His research has contributed to advancements in cancer therapies and diagnostic methods.
Collaborations
Throughout his career, he has collaborated with colleagues including Se Mi Kim and Hye Jin Min. These partnerships have furthered his research and development efforts in the field of monoclonal antibodies.
Conclusion
Sang Jick Kim's innovative work in monoclonal antibody research has the potential to significantly impact cancer treatment and diagnosis. His contributions to biotechnology continue to pave the way for future advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.